The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Infective Vaccines Market Research Report 2025
Synopsis
Anti-infective vaccines, often referred to as vaccines or immunizations, are preventive measures designed to protect individuals from various infectious diseases caused by bacteria, viruses, or other pathogens. Vaccines stimulate the immune system to recognize and fight specific pathogens, thereby preventing infection or reducing the severity of the disease if infection occurs.
The global Anti-Infective Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-Infective Vaccines include Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics and Barr Labs, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Vaccines.
Report Scope
The Anti-Infective Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infective Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
Segment by Type
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
Segment by Application
Bacterial Diseases
Viral Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infective Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infective Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-infective vaccines, often referred to as vaccines or immunizations, are preventive measures designed to protect individuals from various infectious diseases caused by bacteria, viruses, or other pathogens. Vaccines stimulate the immune system to recognize and fight specific pathogens, thereby preventing infection or reducing the severity of the disease if infection occurs.
The global Anti-Infective Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-Infective Vaccines include Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics and Barr Labs, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Vaccines.
Report Scope
The Anti-Infective Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infective Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
Segment by Type
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
Segment by Application
Bacterial Diseases
Viral Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infective Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infective Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Infective Vaccines Market Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Anti-Infective Vaccines Segment by Type
1.2.1 Global Anti-Infective Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Anti-Infective Vaccines Segment by Application
1.3.1 Global Anti-Infective Vaccines Market Value by Application: (2024-2030)
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Global Anti-Infective Vaccines Market Size Estimates and Forecasts
1.4.1 Global Anti-Infective Vaccines Revenue 2019-2030
1.4.2 Global Anti-Infective Vaccines Sales 2019-2030
1.4.3 Global Anti-Infective Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Infective Vaccines Market Competition by Manufacturers
2.1 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Infective Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Infective Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infective Vaccines, Product Type & Application
2.7 Anti-Infective Vaccines Market Competitive Situation and Trends
2.7.1 Anti-Infective Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infective Vaccines Players Market Share by Revenue
2.7.3 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infective Vaccines Retrospective Market Scenario by Region
3.1 Global Anti-Infective Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Infective Vaccines Global Anti-Infective Vaccines Sales by Region: 2019-2030
3.2.1 Global Anti-Infective Vaccines Sales by Region: 2019-2024
3.2.2 Global Anti-Infective Vaccines Sales by Region: 2025-2030
3.3 Global Anti-Infective Vaccines Global Anti-Infective Vaccines Revenue by Region: 2019-2030
3.3.1 Global Anti-Infective Vaccines Revenue by Region: 2019-2024
3.3.2 Global Anti-Infective Vaccines Revenue by Region: 2025-2030
3.4 North America Anti-Infective Vaccines Market Facts & Figures by Country
3.4.1 North America Anti-Infective Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Infective Vaccines Sales by Country (2019-2030)
3.4.3 North America Anti-Infective Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infective Vaccines Market Facts & Figures by Country
3.5.1 Europe Anti-Infective Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Infective Vaccines Sales by Country (2019-2030)
3.5.3 Europe Anti-Infective Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infective Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Infective Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Infective Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Infective Vaccines Market Facts & Figures by Country
3.7.1 Latin America Anti-Infective Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Infective Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Anti-Infective Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infective Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Infective Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Infective Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Infective Vaccines Sales by Type (2019-2030)
4.1.1 Global Anti-Infective Vaccines Sales by Type (2019-2024)
4.1.2 Global Anti-Infective Vaccines Sales by Type (2025-2030)
4.1.3 Global Anti-Infective Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Anti-Infective Vaccines Revenue by Type (2019-2030)
4.2.1 Global Anti-Infective Vaccines Revenue by Type (2019-2024)
4.2.2 Global Anti-Infective Vaccines Revenue by Type (2025-2030)
4.2.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Infective Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Infective Vaccines Sales by Application (2019-2030)
5.1.1 Global Anti-Infective Vaccines Sales by Application (2019-2024)
5.1.2 Global Anti-Infective Vaccines Sales by Application (2025-2030)
5.1.3 Global Anti-Infective Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Anti-Infective Vaccines Revenue by Application (2019-2030)
5.2.1 Global Anti-Infective Vaccines Revenue by Application (2019-2024)
5.2.2 Global Anti-Infective Vaccines Revenue by Application (2025-2030)
5.2.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Infective Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Emergent BioDefense Operations Lansing Inc.
6.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
6.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
6.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio
6.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Anti-Infective Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck & Co.
6.3.1 Merck & Co. Corporation Information
6.3.2 Merck & Co. Description and Business Overview
6.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co. Anti-Infective Vaccines Product Portfolio
6.3.5 Merck & Co. Recent Developments/Updates
6.4 MedImmune LLC
6.4.1 MedImmune LLC Corporation Information
6.4.2 MedImmune LLC Description and Business Overview
6.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MedImmune LLC Anti-Infective Vaccines Product Portfolio
6.4.5 MedImmune LLC Recent Developments/Updates
6.5 Novartis Vaccines
6.5.1 Novartis Vaccines Corporation Information
6.5.2 Novartis Vaccines Description and Business Overview
6.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Vaccines Anti-Infective Vaccines Product Portfolio
6.5.5 Novartis Vaccines Recent Developments/Updates
6.6 Diagnostics Ltd.
6.6.1 Diagnostics Ltd. Corporation Information
6.6.2 Diagnostics Ltd. Description and Business Overview
6.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio
6.6.5 Diagnostics Ltd. Recent Developments/Updates
6.7 Intercell Biomedical
6.6.1 Intercell Biomedical Corporation Information
6.6.2 Intercell Biomedical Description and Business Overview
6.6.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Intercell Biomedical Anti-Infective Vaccines Product Portfolio
6.7.5 Intercell Biomedical Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Corporation Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MassBiologics Anti-Infective Vaccines Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Barr Labs, Inc.
6.9.1 Barr Labs, Inc. Corporation Information
6.9.2 Barr Labs, Inc. Description and Business Overview
6.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio
6.9.5 Barr Labs, Inc. Recent Developments/Updates
6.10 Organon Teknika Co.
6.10.1 Organon Teknika Co. Corporation Information
6.10.2 Organon Teknika Co. Description and Business Overview
6.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Organon Teknika Co. Anti-Infective Vaccines Product Portfolio
6.10.5 Organon Teknika Co. Recent Developments/Updates
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Corporation Information
6.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Description and Business Overview
6.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio
6.11.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.12 CSL Ltd.
6.12.1 CSL Ltd. Corporation Information
6.12.2 CSL Ltd. Anti-Infective Vaccines Description and Business Overview
6.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CSL Ltd. Anti-Infective Vaccines Product Portfolio
6.12.5 CSL Ltd. Recent Developments/Updates
6.13 ID Biomedical Co.
6.13.1 ID Biomedical Co. Corporation Information
6.13.2 ID Biomedical Co. Anti-Infective Vaccines Description and Business Overview
6.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ID Biomedical Co. Anti-Infective Vaccines Product Portfolio
6.13.5 ID Biomedical Co. Recent Developments/Updates
6.14 Protein Sciences Co.
6.14.1 Protein Sciences Co. Corporation Information
6.14.2 Protein Sciences Co. Anti-Infective Vaccines Description and Business Overview
6.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Protein Sciences Co. Anti-Infective Vaccines Product Portfolio
6.14.5 Protein Sciences Co. Recent Developments/Updates
6.15 Wyeth Pharmaceuticals, Inc.
6.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
6.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Description and Business Overview
6.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio
6.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
6.16 Berna Biotech
6.16.1 Berna Biotech Corporation Information
6.16.2 Berna Biotech Anti-Infective Vaccines Description and Business Overview
6.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Berna Biotech Anti-Infective Vaccines Product Portfolio
6.16.5 Berna Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infective Vaccines Industry Chain Analysis
7.2 Anti-Infective Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infective Vaccines Production Mode & Process
7.4 Anti-Infective Vaccines Sales and Marketing
7.4.1 Anti-Infective Vaccines Sales Channels
7.4.2 Anti-Infective Vaccines Distributors
7.5 Anti-Infective Vaccines Customers
8 Anti-Infective Vaccines Market Dynamics
8.1 Anti-Infective Vaccines Industry Trends
8.2 Anti-Infective Vaccines Market Drivers
8.3 Anti-Infective Vaccines Market Challenges
8.4 Anti-Infective Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-Infective Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Infective Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Infective Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Infective Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Infective Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Infective Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Infective Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Infective Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Infective Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Infective Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Infective Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Infective Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Infective Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Infective Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Infective Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Infective Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Infective Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Infective Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Infective Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Infective Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Infective Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Infective Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Infective Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Infective Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Infective Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Infective Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Infective Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Infective Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Infective Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Infective Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Infective Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Infective Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Infective Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Infective Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Infective Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Infective Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Infective Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Infective Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Infective Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Infective Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Infective Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Infective Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Infective Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Infective Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Infective Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Infective Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Infective Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Infective Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Infective Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-Infective Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Infective Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Infective Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Infective Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Infective Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Infective Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Infective Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Infective Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2025-2030)
Table 70. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 71. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 72. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 74. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Pasteur Anti-Infective Vaccines Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Merck & Co. Corporation Information
Table 81. Merck & Co. Description and Business Overview
Table 82. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck & Co. Anti-Infective Vaccines Product
Table 84. Merck & Co. Recent Developments/Updates
Table 85. MedImmune LLC Corporation Information
Table 86. MedImmune LLC Description and Business Overview
Table 87. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. MedImmune LLC Anti-Infective Vaccines Product
Table 89. MedImmune LLC Recent Developments/Updates
Table 90. Novartis Vaccines Corporation Information
Table 91. Novartis Vaccines Description and Business Overview
Table 92. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Vaccines Anti-Infective Vaccines Product
Table 94. Novartis Vaccines Recent Developments/Updates
Table 95. Diagnostics Ltd. Corporation Information
Table 96. Diagnostics Ltd. Description and Business Overview
Table 97. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Diagnostics Ltd. Anti-Infective Vaccines Product
Table 99. Diagnostics Ltd. Recent Developments/Updates
Table 100. Intercell Biomedical Corporation Information
Table 101. Intercell Biomedical Description and Business Overview
Table 102. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Intercell Biomedical Anti-Infective Vaccines Product
Table 104. Intercell Biomedical Recent Developments/Updates
Table 105. MassBiologics Corporation Information
Table 106. MassBiologics Description and Business Overview
Table 107. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. MassBiologics Anti-Infective Vaccines Product
Table 109. MassBiologics Recent Developments/Updates
Table 110. Barr Labs, Inc. Corporation Information
Table 111. Barr Labs, Inc. Description and Business Overview
Table 112. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Barr Labs, Inc. Anti-Infective Vaccines Product
Table 114. Barr Labs, Inc. Recent Developments/Updates
Table 115. Organon Teknika Co. Corporation Information
Table 116. Organon Teknika Co. Description and Business Overview
Table 117. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Organon Teknika Co. Anti-Infective Vaccines Product
Table 119. Organon Teknika Co. Recent Developments/Updates
Table 120. GlaxoSmithKline Biologicals Corporation Information
Table 121. GlaxoSmithKline Biologicals Description and Business Overview
Table 122. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product
Table 124. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 125. CSL Ltd. Corporation Information
Table 126. CSL Ltd. Description and Business Overview
Table 127. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. CSL Ltd. Anti-Infective Vaccines Product
Table 129. CSL Ltd. Recent Developments/Updates
Table 130. ID Biomedical Co. Corporation Information
Table 131. ID Biomedical Co. Description and Business Overview
Table 132. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ID Biomedical Co. Anti-Infective Vaccines Product
Table 134. ID Biomedical Co. Recent Developments/Updates
Table 135. Protein Sciences Co. Corporation Information
Table 136. Protein Sciences Co. Description and Business Overview
Table 137. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Protein Sciences Co. Anti-Infective Vaccines Product
Table 139. Protein Sciences Co. Recent Developments/Updates
Table 140. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 141. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 142. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product
Table 144. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 145. Berna Biotech Corporation Information
Table 146. Berna Biotech Description and Business Overview
Table 147. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Berna Biotech Anti-Infective Vaccines Product
Table 149. Berna Biotech Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Anti-Infective Vaccines Distributors List
Table 153. Anti-Infective Vaccines Customers List
Table 154. Anti-Infective Vaccines Market Trends
Table 155. Anti-Infective Vaccines Market Drivers
Table 156. Anti-Infective Vaccines Market Challenges
Table 157. Anti-Infective Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Infective Vaccines
Figure 2. Global Anti-Infective Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Infective Vaccines Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Live/attenuated Vaccines Product Picture
Figure 7. Global Anti-Infective Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti-Infective Vaccines Market Share by Application in 2023 & 2030
Figure 9. Bacterial Diseases
Figure 10. Viral Diseases
Figure 11. Global Anti-Infective Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-Infective Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti-Infective Vaccines Sales (2019-2030) & (K Units)
Figure 14. Global Anti-Infective Vaccines Average Price (US$/Unit) & (2019-2030)
Figure 15. Anti-Infective Vaccines Report Years Considered
Figure 16. Anti-Infective Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Anti-Infective Vaccines Players: Market Share by Revenue in 2023
Figure 19. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Anti-Infective Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti-Infective Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America Anti-Infective Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti-Infective Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti-Infective Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Anti-Infective Vaccines Sales Market Share by Country (2019-2030)
Figure 45. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Anti-Infective Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Infective Vaccines by Type (2019-2030)
Figure 55. Global Revenue Market Share of Anti-Infective Vaccines by Type (2019-2030)
Figure 56. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Anti-Infective Vaccines by Application (2019-2030)
Figure 58. Global Revenue Market Share of Anti-Infective Vaccines by Application (2019-2030)
Figure 59. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2019-2030)
Figure 60. Anti-Infective Vaccines Value Chain
Figure 61. Anti-Infective Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
